LINK:

OBJECTIVES: Upon completion of this activity, the participant should be able to: 

1  List modifiable risk factors for Alzheimer’s disease.

2. Explain the appropriate use of biomarkers in clinical practice.

3. Utilize pharmacological and nonpharmacological interventions for mood and behavioral symptoms.
 

FACULTY DISCLOSURE: Cindy Marshall, MD, has relevant financial relationship(s) with Eisai as a speaker, advisor with Eisai, Lilly, Lantheus, and Alector, and researcher with Alzheimer’s Association

PLANNERS: The planners have no relevant financial relationship(s) with companies who primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For assistance please contact Jamie Davidson at Jamie.Davidson@BSWHealth.org

Session date: 
06/26/2025 - 12:30pm to 1:30pm CDT
Location: 
Baylor Scott and White Medical Center - Plano
4700 Alliance Blvd
Last 4th or 5th Thursdays, Monthly
Plano, TX 75093
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance
Please login or register for this course.